Calendar

COMPLETEDphase readoutNCT07630909: Mesotherapy for the Management of Myofascial Pain Syndrome

Sponsor: Future University in Egypt. Phase: NA. Conditions: Myofascial Pain Syndrome (MPS)

RECRUITINGphase readoutNCT06413498: A Study Comparing Anitocabtagene Autoleucel to Standard of Care Therapy in Participants With Relapsed/ Refractory Multiple Myeloma

Sponsor: Kite, A Gilead Company. Phase: PHASE3. Conditions: Multiple Myeloma

full page →ctgov ↗

RECRUITINGphase readoutNCT04163198: Optimisation of Mechanical Insufflation:Exsufflation

Sponsor: Guy's and St Thomas' NHS Foundation Trust. Phase: NA. Conditions: Neuromuscular Diseases

full page →ctgov ↗

SUSPENDEDphase readoutNCT06213298: Effect of Kava on Anxiety and Stress in Cancer Survivors

Sponsor: Masonic Cancer Center, University of Minnesota. Phase: EARLY_PHASE1. Conditions: Kava, Anxiety, Stress, Cancer, Depression, Sleep

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT06131398: A Study of AMG 355 Alone and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors

Sponsor: Amgen. Phase: PHASE1. Conditions: Advanced Solid Tumors

full page →ctgov ↗

RECRUITINGphase readoutNCT06412198: A Multicenter Phase 1b/2 Study of Adagrasib, Cetuximab, and Cemiplimab for Metastatic Colorectal Cancer Harboring KRAS G12C Mutations

Sponsor: M.D. Anderson Cancer Center. Phase: PHASE1. Conditions: Metastatic Colorectal Cancer, KRAS G12C Mutations

full page →ctgov ↗

RECRUITINGphase readoutNCT05689463: Evaluation of the Prevalence of BP180 and BP230 Autoantibodies in the Serum of Patients With Pruritus Under Immunotherapy

Sponsor: University Hospital, Rouen. Phase: NA. Conditions: Patients With Chronic Pruritus for More Than 1 Month Who Have Received Immunotherapy

full page →ctgov ↗

RECRUITINGphase readoutNCT07246863: Trial Investigating Visugromab and Nivolumab With or Without Docetaxel in 2L Treatment of Participants With Metastatic NSCLC

Sponsor: CatalYm GmbH. Phase: PHASE2. Conditions: Metastatic Non-Squamous Non-Small Cell Lung Cancer, Adult Solid Tumor

full page →ctgov ↗

COMPLETEDphase readoutNCT05501093: Diabetes Reversal and the Subgingival Microbiota

Sponsor: University of Pennsylvania. Phase: . Conditions: Diabetes type2, Bariatric Surgery Candidate

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07590193: A Trial Evaluating AMG 127 in Healthy Participants and Participants With Type 2 Diabetes Mellitus

Sponsor: Amgen. Phase: PHASE1. Conditions: Diabetes Mellitus, Type 2

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT04211714: Study to Evaluate of EXG34217 in Patients With Telomere Biology Disorders With Bone Marrow Failure

Sponsor: Elixirgen Therapeutics, Inc.. Phase: PHASE1. Conditions: Telomere Shortening, Bone Marrow Failure

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07400016: Efficacy of Superoxide Dismutase Spray in Preventing Radiation Dermatitis in Patients With Head and Neck Cancer .

Sponsor: West China Hospital. Phase: NA. Conditions: Radiation Dermatitis

full page →ctgov ↗

RECRUITINGphase readoutNCT04889716: CAR-T Followed by Bispecific Antibodies

Sponsor: Abramson Cancer Center at Penn Medicine. Phase: PHASE2. Conditions: Large B-cell Lymphoma, DLBCL - Diffuse Large B Cell Lymphoma

full page →ctgov ↗

TERMINATEDphase readoutNCT04347616: Natural Killer-cell Therapy for Acute Myeloid Leukemia

Sponsor: Radboud University Medical Center. Phase: PHASE1. Conditions: Acute Myeloid Leukemia Refractory, Acute Myeloid Leukemia, Relapsed, Adult

full page →ctgov ↗

COMPLETEDphase readoutNCT06632652: Telenursing System by Providing Health Education and Lifestyle Modification Among Diabetic Patients in Bangladesh

Sponsor: Hiroshima University. Phase: NA. Conditions: Diabetes Mellitus

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT05809752: A First in Human Dose Escalation of Dendritic Cell Vaccine (DCV)

Sponsor: H. Lee Moffitt Cancer Center and Research Institute. Phase: PHASE1. Conditions: Leptomeningeal Disease, Triple Negative Breast Cancer, HER2-positive Breast Cancer

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT01984138: REVIVE: Replens Versus Intra-Vaginal Estrogen for the Treatment of Vaginal Dryness on Aromatase Inhibitor Therapy

Sponsor: Polly A. Niravath, MD. Phase: PHASE2. Conditions: Estrogen Receptor Positive Breast Cancer, Breast Cancer

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT04271358: Peer Coaching Intervention in Young Adults With Congenital Heart Disease

Sponsor: Duke University. Phase: NA. Conditions: Congenital Heart Disease, Congenital Heart Defect

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT05933655: Re-thinking the Role of Peers And Training Patients [RePeAT]

Sponsor: University of Rochester. Phase: NA. Conditions: Cardiovascular Diseases

full page →ctgov ↗

RECRUITINGphase readoutNCT05904548: Atrial Flutter Ablation in the iCMR

Sponsor: Imricor Medical Systems. Phase: NA. Conditions: Atrial Flutter Typical

full page →ctgov ↗

COMPLETEDphase readoutNCT02638155: Food Addiction and Hormone Study

Sponsor: Texas Tech University. Phase: . Conditions: Disordered Eating

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07543939: Peak Airway Pressure and Respiratory Mechanics During PRVC Ventilation in Laparoscopic Surgery

Sponsor: Specialized Medical Center (SMC). Phase: . Conditions: Intraoperative Ventilation, Respiratory Mechanics

full page →ctgov ↗

RECRUITINGphase readoutNCT07252739: KEYMAKER-U01 Substudy 01J: A Study of Pembrolizumab Plus MK-1084 in Participants With Non-Small Cell Lung Cancer (NSCLC) With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) G12C Mutations (MK-3475-01J/KEYMAKER-U01J)

Sponsor: Merck Sharp & Dohme LLC. Phase: PHASE2. Conditions: Malignant Neoplasm

full page →ctgov ↗

RECRUITINGphase readoutNCT07426757: An Open-Label Study to Evaluate PF-07994525 in Participants With Advanced Cancers

Sponsor: Pfizer. Phase: PHASE1. Conditions: Advanced Malignancies, Advanced Cancer

full page →ctgov ↗

COMPLETEDphase readoutNCT06165601: Proteinuria in Renal Transplant Patients Treated With Dapagliflozin

Sponsor: University Hospital, Montpellier. Phase: NA. Conditions: Chronic Kidney Diseases

full page →ctgov ↗

WITHHELDphase readoutNCT06546501: [Trial of device that is not approved or cleared by the U.S. FDA]

Sponsor: [Redacted]. Phase: . Conditions:

full page →ctgov ↗

RECRUITINGphase readoutNCT05876312: Safety, Tolerability, PK and PD of ADX-038 in Healthy Participants and Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients

Sponsor: ADARx Pharmaceuticals, Inc.. Phase: PHASE1. Conditions: Paroxysmal Nocturnal Hemoglobinuria (PNH)

full page →ctgov ↗

RECRUITINGphase readoutNCT07569419: Proof of Principle Study for an Efficacy Trial of Linaclotide for Cystic Fibrosis

Sponsor: University of Nottingham. Phase: EARLY_PHASE1. Conditions: Cystic Fibrosis (CF)

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT06965465: A Study to Learn How Different Amounts of the Study Medicine Called PF-07999415 Are Tolerated and Act in the Body in Healthy Adults

Sponsor: Pfizer. Phase: PHASE1. Conditions: Healthy

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT05023967: Metformin and Nightly Fasting in Women With Early Breast Cancer

Sponsor: M.D. Anderson Cancer Center. Phase: PHASE2. Conditions: Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Breast Ductal Carcinoma In Situ, Invasive Breast Carcinoma

full page →ctgov ↗

COMPLETEDphase readoutNCT07618507: Resistance Profile to Antiretroviral Medications in Individuals Living With HIV Who Failed a First-Line Regimen With Tenofovir / Lamivudina and Dolutegravir in Brasil

Sponsor: Federal University of São Paulo. Phase: NA. Conditions: HIV, HIV -1 Infection

full page →ctgov ↗

TERMINATEDphase readoutNCT03968107: Diagnostic Performance of Antenatal Ultrasound for High-Risk Intestinal Malrotation

Sponsor: University Hospital, Montpellier. Phase: . Conditions: Pregnancy Related

full page →ctgov ↗

RECRUITINGphase readoutNCT07413692: BTL-699-2 and HPM-6000UF Devices for the Improvement of Depressive Symptoms and Urinary Incontinence in Postpartum and Early Post-Childbirth Women

Sponsor: BTL Industries Ltd.. Phase: NA. Conditions: Depressive Symptoms, Urinary Incontinence

full page →ctgov ↗

RECRUITINGphase readoutNCT05461092: Regional Nerve Blocks to Improve Analgesia and Recovery in Older Adults Undergoing Spinal Fusion

Sponsor: University of Iowa. Phase: EARLY_PHASE1. Conditions: Delirium, Pain, Back, Spinal Fusion, Thoracolumbar Interfascial Plane Block

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07505836: Phase Ⅲ Trial of Group ACYW135 Meningococcal Conjugate Vaccine in Children Aged 12-23 Months

Sponsor: Sinovac Biotech Co., Ltd. Phase: PHASE3. Conditions: Epidemic Meningitis, Meningococcal Vaccines

full page →ctgov ↗

RECRUITINGphase readoutNCT07382336: A Mobile Application for Early Detection and Symptoms Trajectories of Postpartum Depression Using Ecological Momentary Assessment (EMA)

Sponsor: The Hong Kong Polytechnic University. Phase: . Conditions: Postpartum Depression (PPD)

full page →ctgov ↗

RECRUITINGphase readoutNCT07605936: Frailty in Older Adults With Prostate Cancer: a Prospective Cohort Study

Sponsor: University of Limerick. Phase: . Conditions: Frailty at Older Adults, Prostate Cancer

full page →ctgov ↗

RECRUITINGphase readoutNCT07244211: MAPT Protocol: Fixation Versus Arthroplasty Surgical Treatments for Early Recovery After HIP Fracture (FASTER-HIP)

Sponsor: University of Southern California. Phase: NA. Conditions: Femoral Neck Fractures

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT04633811: Effect of Weight Loss on Urinary Oxalate Excretion in Obese Calcium Oxalate Kidney Stone Formers

Sponsor: University of Alabama at Birmingham. Phase: NA. Conditions: Kidney Stone

full page →ctgov ↗

RECRUITINGphase readoutNCT07197944: Efficacy And Safety Evaluation of Glepaglutide in Treatment of SBS

Sponsor: Zealand Pharma. Phase: PHASE3. Conditions: Short Bowel Syndrome

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT06894849: Text -Based Depression Screening Among Cancer Survivors

Sponsor: Medical University of South Carolina. Phase: NA. Conditions: Cancer, Depression Secondary to Other Disease, Cancer Survivor

full page →ctgov ↗

RECRUITINGphase readoutNCT06045338: Mind Body Intervention for Long COVID-19

Sponsor: Beth Israel Deaconess Medical Center. Phase: NA. Conditions: Long COVID, Post-Acute Sequelae of COVID-19, COVID Long-Haul

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT07494058: A Study of Home vs Hospital Treatment in People With Fabry, Gaucher or Hunter Conditions in Mexico

Sponsor: Takeda. Phase: . Conditions: Lysosomal Disease

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT03253848: Simplified Patient Care Strategy in Decreasing Early Death in Patients With Acute Promyelocytic Leukemia

Sponsor: ECOG-ACRIN Cancer Research Group. Phase: NA. Conditions: Acute Promyelocytic Leukemia With PML-RARA, t(15;17)

full page →ctgov ↗

RECRUITINGphase readoutNCT07394855: Mechanisms of Persistent Fatigue

Sponsor: University Hospital, Akershus. Phase: . Conditions: Fatigue Post Viral

full page →ctgov ↗

COMPLETEDphase readoutNCT07249658: Effects of Power and High-Intensity Gait Training for Functional Mobility an Ambulation in Chronic Stroke

Sponsor: Riphah International University. Phase: NA. Conditions: Stroke

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT06508658: A Study of Subcutaneously Injected Epcoritamab Plus Oral Lenalidomide Tablets Compared to Intravenously (IV) Infused Rituximab Plus IV Infused Gemcitabine and IV Infused Oxaliplatin in Adult Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Sponsor: Genmab. Phase: PHASE3. Conditions: Diffuse Large B-Cell Lymphoma

full page →ctgov ↗

RECRUITINGphase readoutNCT07257055: Phase 2 Study of BTKi-Rituximab Induction Followed by Glofitamab Consolidation in High Risk Untreated MCL Patients - WINDOW-4 Study

Sponsor: M.D. Anderson Cancer Center. Phase: PHASE2. Conditions: Phase 2 Study, MCL, BTKi, Rituximab, Glofitamab

full page →ctgov ↗

COMPLETEDphase readoutNCT03315455: Efficacy, Safety, and Pharmacokinetic Study of Prophylactic Emicizumab Versus No Prophylaxis in Hemophilia A Participants

Sponsor: Hoffmann-La Roche. Phase: PHASE3. Conditions: Hemophilia A

full page →ctgov ↗

COMPLETEDphase readoutNCT06047548: A Study of LY3298176 (Tirzepatide) For the Maintenance of Body Weight Reduction in Participants Who Have Obesity or Overweight With Weight-Related Comorbidities

Sponsor: Eli Lilly and Company. Phase: PHASE3. Conditions: Overweight, Obesity

full page →ctgov ↗

Date TBD